RISING PHARMACEUTICALS

3 FDA enforcement actions

3 Total Recalls

0 Class I

3 Class II

0 Class III

Firm Details

Product Types: drug
States: NJ

All Recalls

Class II: Risk 02/15/2023 drug

Failed Impurities/Degradation Specifications
Class II: Risk 02/07/2022 drug

Failed Tablet Specifications: Recall of this drug product was voluntarily initiated by the manufacturer due to a market complaint, which stated that a tablet in the sealed bottle was twice larger in size when compared to the remaining tablets. This complaint is second of its kind.
Class II: Risk 09/02/2021 drug

Labeling: Incorrect Instructions

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.